| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.2 | 9e-05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.22 | 0.0001 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0003 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |